Ondine Biomedical Inc. (LON:OBI - Get Free Report)'s stock price shot up 0.2% during mid-day trading on Friday . The stock traded as high as C$8.52 and last traded at C$8.52. 16,596 shares traded hands during mid-day trading, a decline of 93% from the average session volume of 240,821 shares. The stock had previously closed at C$8.50.
Ondine Biomedical Price Performance
The company has a debt-to-equity ratio of 25.95, a current ratio of 1.36 and a quick ratio of 8.26. The company has a 50-day moving average price of C$9.08 and a 200-day moving average price of C$9.59. The firm has a market capitalization of C$64.71 million, a PE ratio of -2.71 and a beta of 0.10.
About Ondine Biomedical
(
Get Free Report)
Ondine Biomedical is a life sciences company leading the charge in breakthrough photodisinfection-based therapies to prevent and treat serious infections, including those caused by existing, emerging, and antimicrobial-resistant pathogens.
Our vision is a world free from infections. We have created a patented, platform technology (photodisinfection) to provide simple solutions to complex infections across different therapeutic areas in healthcare and industry settings.
Recommended Stories
Before you consider Ondine Biomedical, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Ondine Biomedical wasn't on the list.
While Ondine Biomedical currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the top 7 AI stocks to invest in right now. This exclusive report highlights the companies leading the AI revolution and shaping the future of technology in 2025.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
